73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Improving treatment for hairy cell leukemia

Improving treatment for hairy cell leukemia

by Melissa Rohman,Northwestern UniversityCredit: Unsplash/CC0 Public DomainPatients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent respon

Improving treatment for hairy cell leukemia

by Melissa Rohman,Northwestern UniversityCredit: Unsplash/CC0 Public DomainPatients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent respon
Enfortumab Vedotin Plus Pembrolizumab Generates Survival Benefit in Previously Untreated

Enfortumab Vedotin Plus Pembrolizumab Generates Survival Benefit in Previously Untreated

September 22, 2023Chris RyanTreatment with the combination of enfortumab Vedotin and pembrolizumab led to an improvement in overall survival and progression-free survival compared with chemotherapy in

Enfortumab Vedotin Plus Pembrolizumab Generates Survival Benefit in Previously Untreated

September 22, 2023Chris RyanTreatment with the combination of enfortumab Vedotin and pembrolizumab led to an improvement in overall survival and progression-free survival compared with chemotherapy in
Trial demonstrates acute lymphoblastic leukemia treatment advance

Trial demonstrates acute lymphoblastic leukemia treatment advance

by Diane Dragaud, ECOG-ACRIN Cancer Research GroupCredit:LBA-1 Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblas

Trial demonstrates acute lymphoblastic leukemia treatment advance

by Diane Dragaud, ECOG-ACRIN Cancer Research GroupCredit:LBA-1 Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblas
What you need to know after a breast cancer diagnosis

What you need to know after a breast cancer diagnosis

by Robin FosterBreast cancer strikes 1 in 8 women in the United States, but being diagnosed with the disease can still make you feel alone.To cope with such devastating news, breast cancer surgeons fr

What you need to know after a breast cancer diagnosis

by Robin FosterBreast cancer strikes 1 in 8 women in the United States, but being diagnosed with the disease can still make you feel alone.To cope with such devastating news, breast cancer surgeons fr
How employers can help cancer survivors return to work

How employers can help cancer survivors return to work

by Stephen Bevan,The ConversationCredit: AI-generated imageWhen I lost a relative to cancer in the late 1970s, people usually viewed a cancer diagnosis with horror. At the time, many treatments

How employers can help cancer survivors return to work

by Stephen Bevan,The ConversationCredit: AI-generated imageWhen I lost a relative to cancer in the late 1970s, people usually viewed a cancer diagnosis with horror. At the time, many treatments
HDAC6 score found to predict the response of some cancers to ricolinostat

HDAC6 score found to predict the response of some cancers to ricolinostat

by Bob Yirka , Medical XpressHDAC6 score in BC. (a) The number of samples and dataset of origin used to evaluate the HDAC6 regulon. (b) Overlap of the original and updated HDAC6 regulons. P value was

HDAC6 score found to predict the response of some cancers to ricolinostat

by Bob Yirka , Medical XpressHDAC6 score in BC. (a) The number of samples and dataset of origin used to evaluate the HDAC6 regulon. (b) Overlap of the original and updated HDAC6 regulons. P value was
Study reviews the role of a ribonucleic acid 'MALAT1' in hematological malignancies

Study reviews the role of a ribonucleic acid 'MALAT1' in hematological malignancies

by Cactus CommunicationsRecent studies have shown that an abnormally high expression of MALAT1 in blood cancer cells could aid the chemotherapeutic resistance development through multiple intermolecul

Study reviews the role of a ribonucleic acid 'MALAT1' in hematological malignancies

by Cactus CommunicationsRecent studies have shown that an abnormally high expression of MALAT1 in blood cancer cells could aid the chemotherapeutic resistance development through multiple intermolecul
Gallbladder and bile duct cancers: Rare, silent and deadly. Know the signs

Gallbladder and bile duct cancers: Rare, silent and deadly. Know the signs

by Cara MurezBile duct and gallbladder cancers develop in organs deep inside the body, making them difficult to detect.Knowing the signs of these rare cancers may help with earlier detection.Gallbladd

Gallbladder and bile duct cancers: Rare, silent and deadly. Know the signs

by Cara MurezBile duct and gallbladder cancers develop in organs deep inside the body, making them difficult to detect.Knowing the signs of these rare cancers may help with earlier detection.Gallbladd
How intestinal cancer stem cells evade anti-angiogenic therapy

How intestinal cancer stem cells evade anti-angiogenic therapy

How intestinal cancer stem cells evade anti-angiogenic therapybyLudwig Cancer ResearchCredit: CC0 Public DomainA team led by Ludwig Lausanne's Tatiana Petrova, Jeremiah Bernier-Latmani and a

How intestinal cancer stem cells evade anti-angiogenic therapy

How intestinal cancer stem cells evade anti-angiogenic therapybyLudwig Cancer ResearchCredit: CC0 Public DomainA team led by Ludwig Lausanne's Tatiana Petrova, Jeremiah Bernier-Latmani and a
Pembrolizumab With COPDAC-28 Consolidation Increases PET Negativity in Classical Hodgkin Lymphoma

Pembrolizumab With COPDAC-28 Consolidation Increases PET Negativity in Classical Hodgkin Lymphoma

August 29, 2023Kyle DohertyThe addition of pembrolizumab to COPDAC-28 consolidation may augment responses to treatment in pediatric and young adult patients with high-risk classical Hodgkin lymphoma w

Pembrolizumab With COPDAC-28 Consolidation Increases PET Negativity in Classical Hodgkin Lymphoma

August 29, 2023Kyle DohertyThe addition of pembrolizumab to COPDAC-28 consolidation may augment responses to treatment in pediatric and young adult patients with high-risk classical Hodgkin lymphoma w
BRAF Mutation: Cancer Types, Testing, Treatment

BRAF Mutation: Cancer Types, Testing, Treatment

BRAF Mutation: Cancer Types, Testing, TreatmentRole of BRAF mutations in melanoma, lung cancer, and moreByLynne Eldridge, MDUpdated on October 14, 2022Medically reviewed byOliv

BRAF Mutation: Cancer Types, Testing, Treatment

BRAF Mutation: Cancer Types, Testing, TreatmentRole of BRAF mutations in melanoma, lung cancer, and moreByLynne Eldridge, MDUpdated on October 14, 2022Medically reviewed byOliv
Researchers identify an Achilles' heel in neuroblastoma

Researchers identify an Achilles' heel in neuroblastoma

by Molly Chiu,Baylor College of MedicineThe image shows magnified neuroblastoma cells. Credit: Baylor College of MedicineNeuroblastoma, a childhood cancer that develops from neural cells on the

Researchers identify an Achilles' heel in neuroblastoma

by Molly Chiu,Baylor College of MedicineThe image shows magnified neuroblastoma cells. Credit: Baylor College of MedicineNeuroblastoma, a childhood cancer that develops from neural cells on the